Scott Swain, PhD, MPH

Articles by Scott Swain, PhD, MPH

Addressing 4 Common Roadblocks When Using RWD in Regulatory Submissions

January 18th 2022

Scott Swain details the most common roadblocks that pharma companies experience when incorporating real-world data (RWD) in regulatory submissions and looks at how they can be addressed.

Latest Updated Articles

Trending on PharmExec

Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement

FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia

From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection

How Nuvation Bio Manages its Ongoing Clinical Trials

Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics